ALX Oncology Holdings Inc
corporate_fare Company Profile
ALX Oncology Holdings Inc (NASDAQ:ALXO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for ALXO at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- ALX Oncology Expands Equity Incentive Plan by 1.3M Shares, Increasing Potential Dilution
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$101.69M
Diluted EPS
-$1.90
Op. Cash Flow
-$84.14M
Free Cash Flow
-$84.35M
Operating Income
-$104.02M
Cash & Equivalents
$16.37M
Total Debt
$9.75M
Debt / Equity
0.38×
Shares Outstanding
54.39M sh
Source: 10-K · filed 2026-03-09 · accession 0001193125-26-098454
show_chartPrice Chart
Loading chart...
feed ALXO - Filings & News (Page 2)
ALXO
Jan 21, 2026, 4:43 PM EST
Price at Filing:
$1.31
Real-time Price:
$0.994
Change:
-$0.3184 (-24%)
Market Cap:
$137.031M